ENANTA PHARMACEUTICALS INC (ENTA) › Shareholders' EquityENANTA PHARMACEUTICALS INC (ENTA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$150.07M2011: -$131.96M2012: -$115.35M2013: $110.47M2014: $148.65M2015: $236.16M2016: $269.94M2017: $301.68M2018: $393.68M2019: $462.49M2020: $455.58M2021: $399.43M2022: $321.33M2023: $216.74M2024: $128.81M2025: $64.72M$64.72M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$64.72M-49.8%2024$128.81M-40.6%2023$216.74M-32.6%2022$321.33M-19.6%2021$399.43M-12.3%2020$455.58M-1.5%2019$462.49M+17.5%2018$393.68M+30.5%2017$301.68M+11.8%2016$269.94M+14.3%2015$236.16M+58.9%2014$148.65M+34.6%2013$110.47M+195.8%2012-$115.35M+12.6%2011-$131.96M+12.1%2010-$150.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share